Proteasome inhibitors are the better characterized members of this group, though recent studies suggest that ER unfolded protein response molecules, such as glucose-regulated protein 78/immunoglobulin heavy-chain binding protein (GPR78/BiP), could also be suitable targets against cancer (Figure 6). This evidence concerns the gene HSPA5 and cancer.